Is pulmonary fibrosis a precancerous disease?

Mahdie Hosseini, Mary Salvatore

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most common type of interstitial lung disease (ILD) characterized by a histopathological pattern of usual interstitial pneumonia with progressive fibrosis of the pulmonary epithelium. The incidence of IPF is increasing worldwide as the population ages and with that, there is a concomitant increase in the incidence of lung cancer in these patients who are living longer with the disease. The average length of time for lung cancer development following an IPF diagnosis is 3 years. Given the high prevalence of lung cancer among patients with pulmonary fibrosis, we wondered if pulmonary fibrosis could be classified as a precancerous disease. We provided support from the Pubmed published literature to investigate whether pulmonary fibrosis meets the five criteria of the National Cancer Institute's definition of premalignant conditions for classification as a precancerous disease. We found out pulmonary fibrosis meets the five criteria of the National Cancer Institute's definition of a premalignant condition and can be considered a precancerous disease. To identify early lung cancer in patients with pulmonary fibrosis, regular screening with HRCT and PET-CT scans is highly recommended for these patients.

Original languageEnglish
Article number110723
JournalEuropean Journal of Radiology
Volume160
DOIs
StatePublished - Mar 2023
Externally publishedYes

Keywords

  • HRCT
  • Lung cancer
  • Precancerous disease
  • Pulmonary fibrosis

Fingerprint

Dive into the research topics of 'Is pulmonary fibrosis a precancerous disease?'. Together they form a unique fingerprint.

Cite this